Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Lung (Small Cell)
Study Phase
Phase 3
Study Completion Date
December 2008
NCT00143455Uploaded 06-29-2020
Available for Download
PDS UID: LungSm_Pfizer_2002_419
Open Label, Randomised Multicentre Phase III Study Of Irinotecan Hydrochloride (Campto (Registered)) And Cisplatin Versus Etoposide And Cisplatin In Chemotherapy Naive Patients With Extensive Disease - Small Cell Lung Cancer
Files:
PROTOCOLXRP4174D-3001 Protocol Amendment 5 15 December 2004_Redacted.pdf
CRFNCT00143455_CRF_README.docx
DATA DICTIONARYNCT00143455_DD_README.docx
DATA (COMPARATOR ARM)XRP4174D-3001_cohort1_CSVfiles.zip
DATA (COMPARATOR ARM)XRP4174D-3001_cohort1_SAS7BDATfiles.zip
DATA (COMPARATOR ARM)XRP4174D-3001_cohort2_CSVfiles.zip
DATA (COMPARATOR ARM)XRP4174D-3001_cohort2_SAS7BDATfiles.zip